Package Leaflet: Information for the User
Viaflo Glucose 5% and Potassium Chloride 0.15%, Solution for Infusion
Active substance: glucose monohydrate and potassium chloride
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Throughout this leaflet, Viaflo Glucose 5% and Potassium Chloride 0.15% Solution for Infusion is referred to as Viaflo Glucose 5% and Potassium Chloride 0.15%.
Contents of the pack and other information:
Viaflo Glucose 5% and Potassium Chloride 0.15% is a solution of glucose and potassium chloride in water. Potassium chloride is a chemical substance (commonly called "a salt") that is found in the blood.
Glucose is one of the body's sources of energy. This infusion solution provides 200 kilocalories per liter.
Viaflo Glucose 5% and Potassium Chloride 0.15% is used as a source of carbohydrates (sugar) in the prevention and treatment of:
Viaflo Glucose 5% and Potassium Chloride 0.15% must not be given to you if you have any of the following conditions:
Warnings and precautions
Tell your doctor if you have or have had any of the following conditions:
Infusion may cause:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain swelling (cerebral edema), and death. Brain swelling increases the risk of death and brain damage. People at higher risk of brain swelling are:
When you are being given this solution, your doctor may take blood and urine samples to check:
Your doctor will consider whether you are receiving parenteral nutrition (nutrition given by vein infusion). During prolonged treatment with Viaflo Glucose 5% and Potassium Chloride 0.15%, you may need to be given extra nutrition.
Children
Viaflo Glucose 5% and Potassium Chloride 0.15% should be given with special care in children.
Newborns - especially premature and low birth weight babies - are at higher risk of developing low or high blood glucose levels (hypo or hyperglycemia) due to glucose solution infusion. Low blood sugar levels in newborns can cause prolonged seizures, coma, and brain damage. High blood sugar levels can cause brain hemorrhage, bacterial or fungal infections, intestinal infections (necrotizing enterocolitis), eye damage (retinopathy of prematurity), lung problems (bronchopulmonary dysplasia), prolonged hospital stay, and death.
The pediatric population should be closely monitored. In cases where normal water regulation in the blood is disturbed due to an increase in the secretion of antidiuretic hormone (ADH), infusion of fluids with low sodium chloride concentration (hypotonic fluids) can cause low sodium levels in the blood (hyponatremia). This can cause headache, nausea, seizures, lethargy, coma, brain swelling (cerebral edema), and death; therefore, these symptoms (acute symptomatic hyponatremic encephalopathy) are considered a medical emergency.
Other medicines and Viaflo Glucose 5% and Potassium Chloride 0.15%
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines.
It is particularly important that you tell your doctor if you are taking medicines that increase potassium levels in the blood, such as:
Some medicines act on the vasopressin hormone. These may include:
Viaflo Glucose 5% and Potassium Chloride 0.15% must not be added to or administered with the same needle used with anticoagulated/conserved blood with citrate. Red blood cells may be damaged or clumped.
Using Viaflo Glucose 5% and Potassium Chloride 0.15% with food and drinks
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
Consult your doctor or nurse before using this medicine. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medicine.
If you are given Viaflo Glucose 5% and Potassium Chloride 0.15% during labor, there is a small chance that glucose may affect the fetus, causing:
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Viaflo Glucose 5% and Potassium Chloride 0.15% does not affect your ability to drive or use machines.
A doctor or nurse will give you the infusion. Your doctor will decide how much you need and when you will be given it, depending on your age, weight, condition, hydration status (the amount of water in your body), and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
You must not be given Viaflo Glucose 5% and Potassium Chloride 0.15% if there are particles floating in the solution or if the container is damaged in any way.
The infusion rate will be decided by your doctor.
If you need a high volume or rapid infusion of Viaflo Glucose 5% and Potassium Chloride 0.15%, your doctor may monitor your ECG (heart graph).
It will usually be given to you through a plastic tube connected to a needle in a vein, usually in your arm. However, your doctor may use another method to give you the medicine.
Before and during the infusion, your doctor will check:
If you have kidney failure, you will receive a lower dose.
Any unused solution should be discarded. You must not be given Viaflo Glucose 5% and Potassium Chloride 0.15% from a bag that has been partially used.
If you are given too much Viaflo Glucose 5% and Potassium Chloride 0.15%
If you are given too much Viaflo Glucose 5% and Potassium Chloride 0.15% (overdose), or if it is infused too quickly, the following symptoms may occur:
If you notice any of these symptoms, you should tell your doctor immediately. Your infusion will be stopped, and you will be treated depending on the symptoms.
If another medicine has been added to Viaflo Glucose 5% and Potassium Chloride 0.15% before the overdose, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
Stopping treatment with Viaflo Glucose 5% and Potassium Chloride 0.15%
Your doctor will decide when you should stop receiving this infusion.
If you have any further questions about the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects:
Side effects that may occur due to the administration technique include:
If another medicine has been added to the infusion solution, it may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
Tell your doctor or nurse if you notice any of the side effects listed or any other.
Reporting side effects:
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the bag after CAD. The expiration date is the last day of the month indicated.
You should not receive this medication if you notice that there are particles floating in the solution or if the container is damaged in any way.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Viaflo Glucose 5% and Potassium Chloride 0.15%
The active ingredients are:
The other ingredients are:
Appearance of the Product and Package Contents
Viaflo Glucose 5% and Potassium Chloride 0.15% is a clear, particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed protective overbag.
The bag sizes are:
The bags are supplied in boxes, each containing the following quantities:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Manufacturer:
Bieffe Medital S.A.
Ctra. Biescas-Senegüé, 22666 Sabiñánigo
(Huesca), Spain
Baxter SA
Boulevard René Branquart, 80
7860 Lessines, Belgium
Date of Last Revision of this Leaflet: August 2020
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
…………………………………………………………………………………………………….
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free of visible particles, and if the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the product's sterility.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air dragged from the primary container before the administration of the liquid contained in the secondary container is completed.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to a gas embolism if the residual air in the container is not fully evacuated before administration. The use of an intravenous administration set with a ventilation filter in the open position could cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open position should not be used with flexible plastic containers.
The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution to prevent air from entering the system.
Added medications can be introduced before or during infusion through the resealable medication addition port.
Medications that are known or determined to be incompatible should not be added.
Before adding a medication, verify that it is soluble and/or stable in Viaflo Glucose 5% and Potassium Chloride 0.15% and that the pH range of Viaflo Glucose 5% and Potassium Chloride 0.15% is appropriate.
You should read the leaflet of the added medication or other relevant documentation.
After adding medications, do not use the solution if there is a change in color and/or the appearance of precipitates, insoluble complexes, or crystals.
Mix the solution completely when adding medications.
Do not store solutions containing added medications.
For single use only.
Discard any unused portion.
When medications are added, the isotonicity should be checked before parenteral administration. It is essential that the mixing of products is done under extreme asepsis conditions. Solutions containing added medications should be used immediately and not stored unless the addition of medications has been carried out under aseptic and validated conditions.
The addition of other medications or the use of an incorrect administration technique can cause the appearance of febrile reactions due to the possible introduction of pyrogens. In the event of an adverse reaction, the infusion should be interrupted immediately.
Pediatric Population
In order to avoid a potentially fatal overdose during the infusion of intravenous solutions to newborns, special attention should be paid to the method of administration. When using a syringe pump to administer fluids or medications intravenously to newborns, a solution bag should not be left connected to the syringe.
When using an infusion pump, all clamps on the intravenous administration equipment should be closed before removing the administration equipment from the pump or disconnecting the pump. This is required regardless of whether the administration equipment has an anti-free flow device.
The intravenous infusion device and administration equipment should be frequently supervised.
Discard after a single use.
Discard unused remnants.
Do not reconnect partially used bags.
Use sterile material for preparation and administration.
To avoid localized hyperkalemia, the solution should not be administered in the atrium or ventricle; it should be administered through a central vein or a large peripheral vein to reduce the risk of sclerosis.
Warning: Added medications may be incompatible (see section 5 "Incompatibilities of Added Medications").
To Add Medication Before Administration
Precaution: Do not store bags with added medication.
To Add Medication During Administration
Before use, the physical and chemical stability of any added medication in the pH of the glucose 5% and potassium chloride 0.15% solution in the Viaflo container should be established.
From a microbiological point of view, the diluted product should be used immediately unless the addition of medications has been carried out under aseptic and validated conditions. If it is not used immediately, the conditions and storage times used before its use are the responsibility of the user.
As with all parenteral solutions, before adding medications, their compatibility with the solution in the Viaflo container should be evaluated.
In the absence of compatibility studies, this solution should not be mixed with other medications.
Before adding a medication, verify that it is soluble and stable in water at the pH of the Viaflo Glucose 5% and Potassium Chloride 0.15% solution (pH: 3.5 – 6.5).
The following list of medications incompatible with Viaflo Glucose 5% and Potassium Chloride 0.15% serves as a guide (non-exhaustive list):
Glucose should not be administered through the same infusion equipment as whole blood, as hemolysis and clot formation may occur.
Medications that are known to be incompatible should not be used.